Enveric Biosciences, Inc.Enveric Biosciences, Inc.Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪7.37 M‬USD
−8.11USD
‪−17.31 M‬USD
‪6.82 M‬
Beta (1Y)
1.94

About Enveric Biosciences, Inc.

CEO
Joseph Tucker
Headquarters
Naples
Employees (FY)
7
Founded
1994
ISIN
US29405E2081
FIGI
BBG000BBQ281
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company was founded on February 28, 1994 and is headquartered in Naples, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ENVB is 0.92 USD — it has decreased by 8.76% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Enveric Biosciences, Inc. stocks are traded under the ticker ENVB.
Enveric Biosciences, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Enveric Biosciences, Inc. has a max estimate of 10.00 USD and a min estimate of 7.00 USD.
ENVB earnings for the last quarter are −1.30 USD whereas the estimation was −2.09 USD which accounts for 37.80% surprise. Estimated earnings for the next quarter are −1.58 USD. See more details about Enveric Biosciences, Inc. earnings.
Yes, you can track Enveric Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ENVB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enveric Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ENVB reached its all-time high on Sep 15, 1995 with the price of 5 503 125.00 USD, and its all-time low was 0.65 USD and was reached on Feb 1, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 7.00 employees. See our rating of the largest employees — is Enveric Biosciences, Inc. on this list?